Alkermes plc (NASDAQ:ALKS) has a beta value of 0.59 and has seen 1.06 million shares traded in the recent trading session. The company, currently valued at $4.47B, closed the recent trade at $26.75 per share which meant it gained $0.82 on the day or 3.18% during that session. The ALKS stock price is -22.92% off its 52-week high price of $32.88 and 23.51% above the 52-week low of $20.46. If we look at the company’s 10-day average daily trading volume, we find that it stood at 1.42 million shares traded. The 3-month trading volume is 1.87 million shares.
Alkermes plc (NASDAQ:ALKS) trade information
Sporting 3.18% in the green today, the stock has traded in the red over the last five days, when the ALKS stock price touched $26.75 or saw a rise of 2.55%. Year-to-date, Alkermes plc shares have moved -3.55%, while the 5-day performance has seen it change -0.06%. Over the past 30 days, the shares of Alkermes plc (NASDAQ:ALKS) have changed -8.53%. Short interest in the company has seen 14.08 million shares shorted with days to cover at 5.47.
Alkermes plc (ALKS) estimates and forecasts
Figures show that Alkermes plc shares have outperformed across the wider relevant industry. The company’s shares have gained 0.35% over the past 6 months, with this year growth rate of 16.67%, compared to 13.50% for the industry. Other than that, the company has, however, increased its growth outlook for the 2024 fiscal year revenue. Growth estimates for the current quarter are 6,600.00% and 43.60% for the next quarter. Revenue growth from the last financial year stood is estimated to be -8.00%.
9 analysts offering their estimates for the company have set an average revenue estimate of $372.33 million for the current quarter. 8 have an estimated revenue figure of $395.34 million for the next quarter concluding in Jun 2024. Year-ago sales stood $287.6 million and $617.4 million respectively for this quarter and the next, and analysts expect sales will grow by 29.50% for the current quarter and -36.00% for the next.
ALKS Dividends
Alkermes plc is expected to release its next earnings report on February 15 this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
Alkermes plc (NASDAQ:ALKS)’s Major holders
Insiders own 1.26% of the company shares, while shares held by institutions stand at 109.29% with a share float percentage of 110.69%. Investors are also buoyed by the number of investors in a company, with Alkermes plc having a total of 429 institutions that hold shares in the company. The top two institutional holders are Vanguard Group Inc with over 18.59 million shares worth more than $582.01 million. As of Jun 29, 2023, Vanguard Group Inc held 11.16% of shares outstanding.
The other major institutional holder is Blackrock Inc., with the holding of over 16.89 million shares as of Jun 29, 2023. The firm’s total holdings are worth over $528.64 million and represent 10.14% of shares outstanding.
Also the top two Mutual Funds that are holding company’s shares are Vanguard Total Stock Market Index Fund and Vanguard Specialized-Health Care Fund. As of Jun 29, 2023, the former fund manager holds about 3.09% shares in the company for having 5.15 million shares of worth $161.21 million while later fund manager owns 4.62 million shares of worth $135.27 million as of Jul 30, 2023, which makes it owner of about 2.77% of company’s outstanding stock.
